Vaccines (Apr 2024)

Harnessing T-Cells for Enhanced Vaccine Development against Viral Infections

  • Zhen Zhuang,
  • Jianfen Zhuo,
  • Yaochang Yuan,
  • Zhao Chen,
  • Shengnan Zhang,
  • Airu Zhu,
  • Jingxian Zhao,
  • Jincun Zhao

DOI
https://doi.org/10.3390/vaccines12050478
Journal volume & issue
Vol. 12, no. 5
p. 478

Abstract

Read online

Despite significant strides in vaccine research and the availability of vaccines for many infectious diseases, the threat posed by both known and emerging infectious diseases persists. Moreover, breakthrough infections following vaccination remain a concern. Therefore, the development of novel vaccines is imperative. These vaccines must exhibit robust protective efficacy, broad-spectrum coverage, and long-lasting immunity. One promising avenue in vaccine development lies in leveraging T-cells, which play a crucial role in adaptive immunity and regulate immune responses during viral infections. T-cell recognition can target highly variable or conserved viral proteins, and memory T-cells offer the potential for durable immunity. Consequently, T-cell-based vaccines hold promise for advancing vaccine development efforts. This review delves into the latest research advancements in T-cell-based vaccines across various platforms and discusses the associated challenges.

Keywords